Vanda Pharmaceuticals, Inc. (VNDA)
7.89
-0.02
(-0.25%)
USD |
NASDAQ |
Mar 06, 16:00
7.895
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals SG&A Expense (TTM) : 237.95M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Gilead Sciences, Inc. | 8.398B |
| Axsome Therapeutics, Inc. | 570.60M |
| Gossamer Bio, Inc. | 36.12M |
| Arcellx, Inc. | 117.76M |